Concert Pharmaceuticals
Utility Patents

Last updated:

List of all Concert Pharmaceuticals patents 12 in total

Status Patent
Grant
Utility: Deuterated EPI-743 External link
Filling date: 7 Sep 2025 Issue date: 8 Mar 2022
Grant
Utility: 4-hydroxybutyric acid analogs External link
Filling date: 7 Sep 2025 Issue date: 2 Nov 2021
Grant
Utility: Deuterated idebenone External link
Filling date: 7 Sep 2025 Issue date: 24 Nov 2020
Grant
Utility: Deuterated baricitinib External link
Filling date: 7 Sep 2025 Issue date: 24 Nov 2020
Grant
Utility: Morphinan compounds External link
Filling date: 7 Sep 2025 Issue date: 27 Oct 2020
Grant
Utility: Deuterated OTX-015 External link
Filling date: 7 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: Deuterated analogs of D-serine and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Treatment of hair loss disorders with deuterated JAK inhibitors External link
Filling date: 7 Sep 2025 Issue date: 18 Feb 2020
Grant
Utility: 4-hydroxybutyric acid analogs External link
Filling date: 7 Sep 2025 Issue date: 14 Jan 2020
Grant
Utility: Deuterated GFT-505 External link
Filling date: 7 Sep 2025 Issue date: 15 Oct 2019
Grant
Utility: Morphinan compounds External link
Filling date: 7 Sep 2025 Issue date: 10 Sep 2019
Grant
Utility: Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase External link
Filling date: 7 Sep 2025 Issue date: 20 Aug 2019

Showing 1 to 12 of 12 patents.